Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders

Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,000.00 and $42,800.00, respectively.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, March 31, 2020
Information
Tags: 
General Health, Hospitals, Health, Nursing, Medical Supplies, Finance, Money, Financial markets, Dividends, Corporate finance, Equity securities, Stock market, Arrears, Debt, Preferred stock
Geotags: 
Texas, United States
⚠generated by AI ↴
Summary
Key Points: 
  • Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,000.00 and $42,800.00, respectively.
  • The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders.
  • Dividends have accrued at 10% per annum and cover amounts in arrears from December 31, 2019 through date of conversion or March 31, 2020 whichever is applicable.
  • The dividends will be paid on April 20, 2020 to shareholders of record as of the close of business on April 10, 2020.


Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,000.00 and $42,800.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from December 31, 2019 through date of conversion or March 31, 2020 whichever is applicable. The dividends will be paid on April 20, 2020 to shareholders of record as of the close of business on April 10, 2020.

Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.

For more information on Retractable, visit its website at www.retractable.com.

Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements.

Factors that could cause or contribute to such differences include, but are not limited to, global pandemics, potential tariffs, Retractable’s ability to maintain liquidity, maintenance of patent protection, litigation, maintenance of favorable third party manufacturing and supplier arrangements and relationships, foreign trade risk, Retractable’s ability to quickly increase capacity in response to an increase in demand, Retractable’s ability to access the market, maintain or decrease production costs, continue to finance research and development as well as operations and expansion of production, the impact of larger market players, specifically Becton Dickinson and Company, in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.

Copyright: 
Copyright Business Wire 2020